SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Larry Hartman who wrote (756)5/28/1997 2:32:00 AM
From: William Presti   of 1172
 
As I have commented before, I believe Chemtrak can capitalize on
their HIV test even if the market for the test kits is not what
was originally envisioned. Why? I predict that J&J will bail as they
did with the Cholesterol-test. Big players want big bucks and if J&J is disappointed, which they probably are, look for them to pull CONFIDE. And how will this affect CMTR? It leaves just them with just one competitor for the whole OTC HIV-test market -- a market which might not be big for a J&J, but big enough for a CMTR. That is my prediction.

Bill

p.s. Anyone want to call Astra Merck directly for info on the impending launch of Hp Chek? I did last time.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext